Executive Summary
This interim event report provides an overview of the Master of Pharmacy (MPharm) program at King's College London as of February 2021. The report evaluates the program's progress since the last accreditation review, focusing on curriculum development, student outcomes, and institutional support despite challenges posed by the COVID-19 pandemic and consequent remote learning adaptations.
Introduction
King's College London has offered pharmacy education since 1847, establishing itself as one of the premier institutions for pharmaceutical education in the United Kingdom. The MPharm program is accredited by the General Pharmaceutical Council (GPhC) and prepares students for professional practice as pharmacists.
Key Achievement: Despite the challenges of the pandemic, King's College London has maintained the quality of the MPharm program while implementing innovative teaching methods and assessment adaptations.
Program Overview
The MPharm program at King's College London is a four-year full-time undergraduate master's degree that provides students with the knowledge and skills required for future pharmacy practice. The program is designed to:
- Develop pharmaceutical knowledge and understanding
- Cultivate professional attitudes and behaviors
- Enhance practical skills through experiential learning
- Foster critical thinking and problem-solving abilities
- Promote patient-centered healthcare approaches
Curriculum Developments
Recent Updates
Since the last review, significant curriculum improvements have been implemented based on student feedback and evolving pharmaceutical practice requirements:
- Integration of more prescribing modules to align with independent prescribing initiatives
- Enhanced content on digital health and telepharmacy
- Incorporation of emerging therapeutic areas including gene therapies and precision medicine
- Increased focus on public health and population pharmacy practice
Covid-19 Adaptations
The pandemic necessitated rapid adaptations to teaching and learning methodologies:
- Transition to primarily online delivery for theoretical components
- Development of virtual simulation tools for practical sessions
- Implementation of alternative assessment methods
- Creation of remote placement opportunities and virtual patient scenarios
Curriculum Mapping
| Program Year | Key Learning Outcomes | Assessment Methods |
|---|---|---|
| Year 1 | Foundational pharmaceutical science, Introduction to professional practice | Written examinations, Practical assessments, Case studies |
| Year 2 | Applied pharmaceutical sciences, Therapeutics, Clinical skills | OSCEs, Written examinations, Project work |
| Year 3 | Clinical therapeutics, Evidence-based practice, Patient care | Integrated case studies, Reflection, Research methods |
| Year 4 | Research project, Practice portfolio, Final assessments |
Student Outcomes and Performance
Academic Performance
Despite the challenges presented by the pandemic transition to remote learning, student performance has remained strong:
- Overall progression rates have maintained at 94% across all years of the program
- Student satisfaction scores in the National Student Survey remain above sector average
- Graduate employability after completion of pre-registration training exceeds 95%
- First-time pass rates in the GPhC registration assessment consistently exceed national averages
Pre-Registration Success
Notable Statistic: King's College London MPharm graduates continue to achieve significantly higher success rates in the GPhC registration assessment than the national average, with a 96% pass rate compared to the sector average of 82% in the most recent assessment period.
Clinical Placement Experiences
Traditional Placements
The MPharm program incorporates extensive experiential learning through placements in various pharmacy practice settings:
- Hospital pharmacy rotations across multiple NHS trusts
- Community pharmacy placements with independent and chain pharmacies
- Primary care network experiences
- Specialist clinical placements in areas such as oncology, pediatrics, and mental health
Pandemic Adaptations
Due to restrictions on physical placements during the pandemic, innovative alternatives were implemented:
- Virtual hospital pharmacies with simulated dispensing workflows
- Remote consultation simulations with standardized patients
- Hospital pharmacy video tours and consultant pharmacist interviews
- Online multidisciplinary team meetings and case discussions
Research and Innovation
Student Research Projects
Final year students engage in extended research projects, many of which have been published in peer-reviewed journals:
- Clinical pharmacokinetics studies
- Medication safety and adherence research
- Pharmaceutical formulation development
- Evaluation of pharmacy services
- Public health interventions
Research Excellence
Research Distinction: The Centre for Pharmaceutical Education Research at King's College London continues to lead innovative pedagogical research in pharmacy education, with several projects focusing on virtual learning approaches and assessment methodology development.
Pedagogical Innovation
Teaching Excellence
The MPharm program has implemented several innovative teaching approaches:
- Interprofessional education opportunities with medical, nursing, and other healthcare students
- Simulation-enhanced learning utilizing advanced patient simulators
- Flipped classroom approaches for targeted content delivery
- Peer-assisted learning initiatives across year groups
- Adaptive learning technologies for personalized education pathways
Technology Integration
Significant investment in technology has enhanced the learning experience:
- Advanced learning management system integration
- Virtual laboratory environments for practical skill development
- Augmented reality applications for anatomy and physiology education
- Digital portfolio tools for documentation of professional development
Student Support
King's College London provides comprehensive support for MPharm students:
- Academic advising and personal tutoring systems
- Specialized study skills support for pharmacy students
- Mental health and wellbeing services
- Career guidance and professional development support
- Financial advice and scholarship opportunities
Staff Development and Expertise
The MPharm program is delivered by multidisciplinary team of experts:
- 60% of teaching staff hold Fellowships of the Higher Education Academy
- Regular continuing professional development for all teaching staff
- Active involvement of service pharmacists in curriculum delivery
- Research-active staff ensuring current knowledge integration
- Specialist expertise in all major therapeutic areas
Pandemic Response and Future Resilience
Immediate Response
The program swiftly adapted to pandemic challenges:
- Rapid conversion to online teaching within two weeks of lockdown
- Redesigned assessments while maintaining academic standards
- Enhanced digital literacy support for both staff and students
- Alternative clinical experience delivery
Future Preparedness
Lessons learned have been incorporated into future planning:
- Hybrid learning models combining online and face-to-face activities
- Enhanced contingency planning for academic continuity
- Further investment in virtual simulation technology
- Flexible assessment strategies resilient to disruption
Future Directions
The program continues to evolve in response to changing pharmacy practice and healthcare needs:
- Greater integration of pharmacogenomics into therapeutics teaching
- Extended focus on digital health and informatics
- Enhanced public health engagement and outbreak preparedness
- Development of leadership and management capabilities
- Strengthened primary care and multidisciplinary team approaches
Conclusion
The MPharm program at King's College London has demonstrated remarkable resilience and adaptability during the challenges posed by the COVID-19 pandemic. While maintaining the high standards expected of a world-class pharmacy education, the program has incorporated significant innovations in pedagogy and assessment. The dedication of staff, the engagement of students, and the support of the institution have ensured continuous quality improvement despite external pressures.
The program remains well-positioned to produce pharmacists equipped for the evolving healthcare landscape, with particular strength in clinical practice, research capability, and adaptability to changing healthcare environments. The ongoing refinements to curriculum, assessment, and delivery methods ensure that graduates are prepared not only for current practice but for future developments in pharmaceutical care.
As the program continues to navigate the transition period following pandemic disruptions, the clear strategic direction combined with operational excellence positions the MPharm program at King's College London as a leader in pharmacy education.
